Excited to share our new Clinical Infectious Diseases paper reporting one of the first real-world evaluations of lenacapavir (LEN) for HIV PrEP in the United States!
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis ✅ Just Accepted 🔗 https://bit.ly/49xAonM